Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
DCGO · Nasdaq · United States · Services-Health Services
In shortDocGo Inc. is loss-making, generates cash and holds more cash than debt, with revenue shrinking (−47.7% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -55.3% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -56.6% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -78.5% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -97.5% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 2.26× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.00× | 100/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -4.05 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 9.3% | 57/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 3 of 5 | 50/100 |
Weight in the score: 20%
| Profitable years (last 5) | 4 of 5 | 80/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 109.5% | 0/100 |
| Operating margin volatility | 26.6% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -9.9% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
1 older year available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 319 | 441 | 624 | 617 | 322 |
| Cost of revenue | 452 | 524 | – | – | – |
| Gross profit | (133) | (83) | – | – | – |
| Research & development | 3.3 | 5.4 | 11 | 12 | 14 |
| Operating income | 15 | 22 | 15 | 29 | (178) |
| Interest expense | 0.1 | 0.1 | – | – | – |
| Pre-tax income | 20 | 23 | 16 | 28 | (187) |
| Income tax | 0.6 | (8) | 6.2 | 14 | 8.9 |
| Net income | 24 | 35 | 6.9 | 20 | (182) |
| Diluted EPS | $0.25 | $0.34 | $0.06 | $0.18 | −$1.84 |
| Diluted shares (millions) | 95 | 103 | 106 | 109 | 99 |
1 older year available with the 10-year history. Essential plan, from €8.25/month →
−4.05 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 17, 2026